Stay updated on QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:43:22.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change likely represents an update or modification in the data related to a Phase 2 clinical study evaluating the safety and efficacy of niraparib in patients with advanced ovarian cancer who have received multiple chemotherapy regimens.
    Difference
    0.1%
    Check dated 2024-06-06T14:47:30.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying requirements such as tumor HRD testing, blood gBRCAmut status testing, and a negative pregnancy serum test for patients of childbearing potential. Previously, the page only listed the dates of the last update submissions and verifications.
    Difference
    21%
    Check dated 2024-05-22T21:35:37.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:55:49.000Z thumbnail image

Stay in the know with updates to QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.